Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.

AUTOR(ES)

Schumacher, C L

RESUMO

Immunization of mice and hamsters with a cocktail of mouse MAbs specific for rabies virus nucleocapsid protein and glycoprotein protected animals not only when challenged with a lethal dose of rabies virus after immunization, but also in post-exposure situations. Hamsters treated with the MAb cocktail 3 h after virus inoculation were completely protected from lethal rabies virus infection, and 80% of the animals survived when the MAb cocktail was given 36 h after virus challenge. The potential usefulness of this MAb cocktail for the postexposure treatment of human rabies is discussed.

Documentos Relacionados

• Retrospective analysis of post-exposure to human anti-rabies treatment in Botucatu, São Paulo State, Brazil
• Assessing anti-rabies baiting – what happens on the ground?
• Antibody and cytokine serum levels in patients submitted to anti-rabies prophylactic treatment with serum vaccination
• Comparison of anti-rabies titles in bovines submitted to five distinct vaccination schedules
• Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine